Publications

Barton JS, Cullen S, Hindmarsh PC, Brook CG, et al. (1992). Growth hormone treatment in idiopathic short stature: a preliminary analysis of cardiovascular effects. Acta Pediatr. Suppl. 383: 35-38.   Bockamp E, Sprengel R, Eshkind L, Lehmann T, et al. (2008). Conditional transgenic mouse models: from the basics to genome-wide sets of knockouts and current studies of tissue regeneration. Regen. Med. 3: 217-235. http://dx.doi.org/10.2217/17460751.3.2.217 PMid:18307405   Dick E, Matsa E, Young L, Darling D, et al. (2011). Accelerating the generation of human induced pluripotent stem cells by coupling high titre lentivirus and column-based positive selection of hiPSCs. Nat. Protoc. 6: 701-714. http://dx.doi.org/10.1038/nprot.2011.320 PMid:21637193   Dull T, Zufferey R, Kelly M, Mandel RJ, et al. (1998). A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72: 8463-8471. PMid:9765382 PMCid:110254   Hens JR, Amstutz MD, Schanbacher FL and Mather IH (2000). Introduction of the human growth hormone gene into the guinea pig mammary gland by in vivo transfection promotes sustained expression of human growth hormone in the milk throughout lactation. Biochim. Biophys. Acta 1523: 161-171. http://dx.doi.org/10.1016/S0304-4165(00)00117-3   Johansen J, Rosenblad C, Andsberg K, Moller A, et al. (2002). Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS. Gene Ther. 9: 1291-1301. http://dx.doi.org/10.1038/sj.gt.3301778 PMid:12224012   Kolb E (1977). Recent findings relating to the importance of growth hormone to both regulation of metabolism and production performance of ruminants (author's transl). Monatsh. Veterinarmed. 32: 230-235. PMid:327288   Krasnov A, Agren JJ, Pitaknen TI and Molsa H (1999). Transfer of growth hormone (GH) transgenes into Arctic charr. (Salvelinus alpinus L.) II. Nutrient partitioning in rapidly growing fish. Genet. Anal. 15: 99-105. http://dx.doi.org/10.1016/S1050-3862(99)00026-1   Lipinski D, Jura J, Kalak R, Plawski A, et al. (2003). Transgenic rabbit producing human growth hormone in milk. J. Appl. Genet. 44: 165-174. PMid:12773794   Madsen K, Friberg U, Roos P, Eden S, et al. (1983). Growth hormone stimulates the proliferation of cultured chondrocytes from rabbit ear and rat rib growth cartilage. Nature 304: 545-547. http://dx.doi.org/10.1038/304545a0 PMid:6877376   Mayo KE, Vale W, Rivier J, Rosenfeld MG, et al. (1983). Expression-cloning and sequence of a cDNA encoding human growth hormone-releasing factor. Nature 306: 86-88. http://dx.doi.org/10.1038/306086a0 PMid:6415488   Naldini L, Blomer U, Gallay P, Ory D, et al. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267. http://dx.doi.org/10.1126/science.272.5259.263 PMid:8602510   Orian JM, Lee CS, Weiss LM and Brandon MR (1989). The expression of a metallothionein-ovine growth hormone fusion gene in transgenic mice does not impair fertility but results in pathological lesions in the liver. Endocrinology 124: 455-463. http://dx.doi.org/10.1210/endo-124-1-455 PMid:2642419   Palmiter RD, Brinster RL, Hammer RE, Trumbauer ME, et al. (1982). Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Nature 300: 611-616. http://dx.doi.org/10.1038/300611a0 PMid:6958982   Takiguchi M, James C, Josefsson EC, Carmichael CL, et al. (2010). Transgenic, inducible RNAi in megakaryocytes and platelets in mice. J. Thromb. Haemost. 8: 2751-2756. http://dx.doi.org/10.1111/j.1538-7836.2010.04077.x PMid:21138522 PMCid:3285240   Wiederschain D, Wee S, Chen L, Loo A, et al. (2009). Single-vector inducible lentiviral RNAi system for oncology target validation. Cell Cycle 8: 498-504. http://dx.doi.org/10.4161/cc.8.3.7701 PMid:19177017

Abramovich D, Irusta G, Parborell F and Tesone M (2010). Intrabursal injection of vascular endothelial growth factor trap in eCG-treated prepubertal rats inhibits proliferation and increases apoptosis of follicular cells involving the PI3K/ AKT signaling pathway. Fertil. Steril. 93: 1369-1377. http://dx.doi.org/10.1016/j.fertnstert.2009.01.127 PMid:19328472   Accili D and Arden KC (2004). FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117: 421-426. http://dx.doi.org/10.1016/S0092-8674(04)00452-0   Barboni B, Turriani M, Galeati G, Spinaci M, et al. (2000). Vascular endothelial growth factor production in growing pig antral follicles. Biol. Reprod. 63: 858-864. http://dx.doi.org/10.1095/biolreprod63.3.858 PMid:10952932   Brummelkamp TR, Bernards R and Agami R (2002). A system for stable expression of short interfering RNAs in mammalian cells. Science 296: 550-553. http://dx.doi.org/10.1126/science.1068999 PMid:11910072   Bruno JB, Celestino JJ, Lima-Verde IB, Lima LF, et al. (2009). Expression of vascular endothelial growth factor (VEGF) receptor in goat ovaries and improvement of in vitro caprine preantral follicle survival and growth with VEGF. Reprod. Fertil. Dev. 21: 679-687. http://dx.doi.org/10.1071/RD08181 PMid:19486605   Celik-Ozenci C, Akkoyunlu G, Kayisli UA, Arici A, et al. (2003). Localization of vascular endothelial growth factor in the zona pellucida of developing ovarian follicles in the rat: a possible role in destiny of follicles. Histochem. Cell Biol. 120: 383-390. http://dx.doi.org/10.1007/s00418-003-0586-4 PMid:14605899   Chang HY, Nishitoh H, Yang X, Ichijo H, et al. (1998). Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx. Science 281: 1860-1863. http://dx.doi.org/10.1126/science.281.5384.1860 PMid:9743501   Danforth DR, Arbogast LK, Ghosh S, Dickerman A, et al. (2003). Vascular endothelial growth factor stimulates preantral follicle growth in the rat ovary. Biol. Reprod. 68: 1736-1741. http://dx.doi.org/10.1095/biolreprod.101.000679 PMid:12606430   Doyle LK, Walker CA and Donadeu FX (2010). VEGF modulates the effects of gonadotropins in granulosa cells. Domest. Anim. Endocrinol. 38: 127-137. http://dx.doi.org/10.1016/j.domaniend.2009.08.008 PMid:19815366   Einspanier R, Schonfelder M, Muller K, Stojkovic M, et al. (2002). Expression of the vascular endothelial growth factor and its receptors and effects of VEGF during in vitro maturation of bovine cumulus-oocyte complexes (COC). Mol. Reprod. Dev. 62: 29-36. http://dx.doi.org/10.1002/mrd.10068 PMid:11933158   Elbashir SM, Harborth J, Lendeckel W, Yalcin A, et al. (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498. http://dx.doi.org/10.1038/35078107 PMid:11373684   Elbashir SM, Harborth J, Weber K and Tuschl T (2002). Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26: 199-213. http://dx.doi.org/10.1016/S1046-2023(02)00023-3   Ferrara N (2002). VEGF and the quest for tumour angiogenesis factors. Nat. Rev. Cancer 2: 795-803. http://dx.doi.org/10.1038/nrc909 PMid:12360282   Giering JC, Grimm D, Storm TA and Kay MA (2008). Expression of shRNA from a tissue-specific pol II promoter is an effective and safe RNAi therapeutic. Mol. Ther. 16: 1630-1636. http://dx.doi.org/10.1038/mt.2008.144 PMid:18665161   Greenaway J, Connor K, Pedersen HG, Coomber BL, et al. (2004). Vascular endothelial growth factor and its receptor, Flk- 1/KDR, are cytoprotective in the extravascular compartment of the ovarian follicle. Endocrinology 145: 2896-2905. http://dx.doi.org/10.1210/en.2003-1620 PMid:14988387   Hannon GJ (2002). RNA interference. Nature 418: 244-251. http://dx.doi.org/10.1038/418244a PMid:12110901   Hicklin DJ and Ellis LM (2005). Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J. Clin. Oncol. 23: 1011-1027. http://dx.doi.org/10.1200/JCO.2005.06.081 PMid:15585754   Irusta G, Abramovich D, Parborell F and Tesone M (2010). Direct survival role of vascular endothelial growth factor (VEGF) on rat ovarian follicular cells. Mol. Cell Endocrinol. 325: 93-100. http://dx.doi.org/10.1016/j.mce.2010.04.018 PMid:20417686   Klagsbrun M and D'Amore PA (1996). Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev. 7: 259-270. http://dx.doi.org/10.1016/S1359-6101(96)00027-5   Kosaka N, Sudo N, Miyamoto A and Shimizu T (2007). Vascular endothelial growth factor (VEGF) suppresses ovarian granulosa cell apoptosis in vitro. Biochem. Biophys. Res. Commun. 363: 733-737. http://dx.doi.org/10.1016/j.bbrc.2007.09.061 PMid:17904528   Lee NS, Dohjima T, Bauer G, Li H, et al. (2002). Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol. 20: 500-505. PMid:11981565   McManus MT and Sharp PA (2002). Gene silencing in mammals by small interfering RNAs. Nat. Rev. Genet. 3: 737-747. http://dx.doi.org/10.1038/nrg908 PMid:12360232   Okamura Y, Myoumoto A, Manabe N, Tanaka N, et al. (2001). Protein tyrosine kinase expression in the porcine ovary. Mol. Hum. Reprod. 7: 723-729. http://dx.doi.org/10.1093/molehr/7.8.723 PMid:11470859   Paul CP, Good PD, Winer I and Engelke DR (2002). Effective expression of small interfering RNA in human cells. Nat. Biotechnol. 20: 505-508. http://dx.doi.org/10.1038/nbt0502-505 PMid:11981566   Petersen CP, Bordeleau ME, Pelletier J and Sharp PA (2006). Short RNAs repress translation after initiation in mammalian cells. Mol. Cell 21: 533-542. http://dx.doi.org/10.1016/j.molcel.2006.01.031 PMid:16483934   Reynolds A, Leake D, Boese Q, Scaringe S, et al. (2004). Rational siRNA design for RNA interference. Nat. Biotechnol. 22: 326-330. http://dx.doi.org/10.1038/nbt936 PMid:14758366   Shen HL, Xu W, Wu ZY, Zhou LL, et al. (2007). Vector-based RNAi approach to isoform-specific downregulation of vascular endothelial growth factor (VEGF)165 expression in human leukemia cells. Leuk. Res. 31: 515-521. http://dx.doi.org/10.1016/j.leukres.2006.09.011 PMid:17034851   Shi Y (2003). Mammalian RNAi for the masses. Trends Genet. 19: 9-12. http://dx.doi.org/10.1016/S0168-9525(02)00005-7   Tamanini C and De Ambrogi M (2004). Angiogenesis in developing follicle and corpus luteum. Reprod. Domest. Anim. 39: 206-216. http://dx.doi.org/10.1111/j.1439-0531.2004.00505.x PMid:15225273   Tang TT and Lasky LA (2003). The forkhead transcription factor FOXO4 induces the down-regulation of hypoxia-inducible factor 1 alpha by a von Hippel-Lindau protein-independent mechanism. J. Biol. Chem. 278: 30125-30135. http://dx.doi.org/10.1074/jbc.M302042200 PMid:12761217   Terman BI and Dougher-Vermazen M (1996). Biological properties of VEGF/VPF receptors. Cancer Metastasis Rev. 15: 159-163. http://dx.doi.org/10.1007/BF00437468 PMid:8842487   Wolters NM and Mackeigan JP (2008). From sequence to function: using RNAi to elucidate mechanisms of human disease. Cell Death Differ. 15: 809-819. http://dx.doi.org/10.1038/sj.cdd.4402311 PMid:18202701   Wulff C, Wilson H, Wiegand SJ, Rudge JS, et al. (2002). Prevention of thecal angiogenesis, antral follicular growth, and ovulation in the primate by treatment with vascular endothelial growth factor Trap R1R2. Endocrinology 143: 2797-2807. http://dx.doi.org/10.1210/en.143.7.2797 PMid:12072415   Yoo JY, Kim JH, Kwon YG, Kim EC, et al. (2007). VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth. Mol. Ther. 15: 295-302. http://dx.doi.org/10.1038/sj.mt.6300023 PMid:17235307   Zhang GY, Yi CG, Li X, Zheng Y, et al. (2008). Inhibition of vascular endothelial growth factor expression in keloid fibroblasts by vector-mediated vascular endothelial growth factor shRNA: a therapeutic potential strategy for keloid. Arch. Dermatol. Res. 300: 177-184. http://dx.doi.org/10.1007/s00403-007-0825-y PMid:18239926   Zhang L, Yang N, Mohamed-Hadley A, Rubin SC, et al. (2003). Vector-based RNAi, a novel tool for isoform-specific knock-down of VEGF and anti-angiogenesis gene therapy of cancer. Biochem. Biophys. Res. Commun. 303: 1169-1178. http://dx.doi.org/10.1016/S0006-291X(03)00495-9